Day 038 - 19 Oct 94 - Page 15


     
     1        other?
     2        A.  Yes, indeed.  Populations of laboratory animals are
     3        typically genetically quite homogeneous.  They will get a
     4        group of very, very similar animals in order that they can,
     5        hopefully, factor out, as it were, genetic variations with
     6        the animals insofar as different effects arise.  They want
     7        to be able to confidently ascribe those to the compound
     8        being tested and not to the variation within the
     9        population.
    10
    11        So, they will use a genetically homogeneous group of
    12        animals; whereas, of course, the human population is far
    13        from genetically homogeneous.  Moreover, all the animals in
    14        the laboratory tests receive the same diet, though the only
    15        variation is that systematic variation in dose.  They are
    16        kept in scrupulously hygenic and (insofar as it is
    17        possible) pathogene free environments and they are,
    18        therefore, free from extraneous illnesses which might
    19        otherwise complicate the reaction of ordinary human
    20        beings.
    21
    22        So, you are using small homogeneous groups of laboratory
    23        animals in a constant environment to model the possible
    24        effects in human populations which are genetically diverse,
    25        occupationally diverse, nutritionally diverse and diverse
    26        in so many other ways.
    27
    28   Q.   And may have ailments?
    29        A.  May indeed have ailments.
    30
    31   Q.   Complications?
    32        A.  Yes; they are not all equally healthy in the way one
    33        would expect a group of laboratory animals to be.
    34
    35   Q.   So does that have an implication for the ten and a 100 risk
    36        factor multiplications?  If you want to go into that in a
    37        bit more detail?
    38        A.  Yes.  Insofar as the regulatory authorities set these
    39        figures called an acceptable daily intake, or ADI, by
    40        reference to the results of animal studies, they will
    41        typically seek to identify in the animal studies what is --
    42        it used to be called "no effect level"; then they called it
    43        "no adverse effect level"; now sometimes they will qualify
    44        that even further and say "no observable adverse effect
    45        level".  But let us suppose you identify a level in the
    46        feeding studies at which no conspicuous adverse effect
    47        emerges.  That level of exposure of the test compound in
    48        the animal is estimated in terms of -- well, the typical
    49        units are milligrams of chemical per kilogram body weight
    50        of the rodent. 
    51 
    52        In then identifying what is referred to as an "acceptable 
    53        daily intake", nominally they are supposed to use a safety
    54        factor which is nominally supposed to be 100.  I should,
    55        however, say that in my scrutiny of the practices,
    56        particularly the Joint Expert Committee on Food Additives,
    57        more commonly other safety factors are used than a 100;
    58        sometimes they are as high as 5,000, sometimes they are as
    59        low as 20.  But let us stick with the nominally standard
    60        safety factor of 100.

Prev Next Index